0001225208-23-002816.txt : 20230224 0001225208-23-002816.hdr.sgml : 20230224 20230224205226 ACCESSION NUMBER: 0001225208-23-002816 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230222 FILED AS OF DATE: 20230224 DATE AS OF CHANGE: 20230224 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McDermott Michael CENTRAL INDEX KEY: 0001902464 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-03619 FILM NUMBER: 23669713 MAIL ADDRESS: STREET 1: C/O PFIZER INC. CORPORATE SECRETARY STREET 2: 235 EAST 42ND STREET CITY: 235 EAST 42ND STREET STATE: NY ZIP: 10017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PFIZER INC CENTRAL INDEX KEY: 0000078003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 135315170 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 66 HUDSON BOULEVARD EAST CITY: NEW YORK STATE: NY ZIP: 10001-2192 BUSINESS PHONE: 2127332323 MAIL ADDRESS: STREET 1: 66 HUDSON BOULEVARD EAST CITY: NEW YORK STATE: NY ZIP: 10001-2192 FORMER COMPANY: FORMER CONFORMED NAME: PFIZER CHARLES & CO INC DATE OF NAME CHANGE: 19710908 4 1 doc4.xml X0306 4 2023-02-22 0000078003 PFIZER INC PFE 0001902464 McDermott Michael 66 HUDSON BOULEVARD EAST ATTN: CORPORATE SECRETARY NEW YORK NY 10001-2192 1 Executive Vice President Common Stock 2023-02-22 4 M 0 13307.0000 30.1700 A 88957.0000 D Common Stock 2023-02-22 4 F 0 1935.0000 42.3800 D 87022.0000 D Common Stock 2023-02-22 4 F 0 8101.0000 43.7000 D 78921.0000 D Stock Appreciation Rights 30.1700 2023-02-22 4 M 0 13307.0000 0.0000 D 2023-02-22 2023-02-22 Common Stock 13307.0000 0.0000 D Stock Appreciation Rights 42.3000 2023-02-23 4 A 0 45920.0000 0.0000 A 2028-02-23 2028-02-23 Common Stock 45920.0000 45920.0000 D Stock Appreciation Rights 42.3000 2023-02-23 4 A 0 39965.0000 0.0000 A 2030-02-23 2030-02-23 Common Stock 39965.0000 39965.0000 D The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Susan E. Grant, by power of atty., for Michael McDermott 2023-02-24